دورية أكاديمية
أعرض في EDS

Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.

التفاصيل البيبلوغرافية
العنوان: Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
المؤلفون: Reedijk AMJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Zijtregtop EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Coebergh JWW; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands., Janssens GOR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Dinmohamed AG; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Zijlstra JM; Department of Hematology location VU Medical Center, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Amsterdam UMC, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Karim-Kos HE; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
المصدر: British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (6), pp. 1093-1106. Date of Electronic Publication: 2020 Feb 06.
نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Wiley-Blackwell
Original Publication: Oxford : Blackwell Scientific Publications
مواضيع طبية MeSH: Registries*, Hodgkin Disease/*mortality, Adolescent ; Adult ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Hodgkin Disease/diagnosis ; Hodgkin Disease/therapy ; Humans ; Incidence ; Male ; Netherlands/epidemiology ; Survival Rate ; Young Adult
مستخلص: Population-based studies that assess long-term patterns of incidence, major aspects of treatment and survival are virtually lacking for Hodgkin lymphoma (HL) at a younger age. This study assessed the progress made for young patients with HL (<25 years at diagnosis) in the Netherlands during 1990-2015. Patient and tumour characteristics were extracted from the population-based Netherlands Cancer Registry. Time trends in incidence and mortality rates were evaluated with average annual percentage change (AAPC) analyses. Stage at diagnosis, initial treatments and site of treatment were studied in relation to observed overall survival (OS). A total of 2619 patients with HL were diagnosed between 1990 and 2015. Incidence rates increased for 18-24-year-old patients (AAPC + 1%, P = 0·01) only. Treatment regimens changed into less radiotherapy and more 'chemotherapy only', different for age group and stage. Patients aged 15-17 years were increasingly treated at a paediatric oncology centre. The 5-year OS for children was already high in the early 1990s (93%). For patients aged 15-17 and 18-24 years the 5-year OS improved from 84% and 90% in 1990-1994 to 96% and 97% in 2010-2015, respectively. Survival for patients aged 15-17 years was not affected by site of treatment. Our present data demonstrate that significant progress in HL treatment has been made in the Netherlands since 1990.
(© 2020 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.)
References: J Clin Oncol. 1989 Nov;7(11):1630-6. (PMID: 2809679)
J Clin Oncol. 2000 Feb;18(3):487-97. (PMID: 10653864)
N Engl J Med. 2010 Aug 12;363(7):640-52. (PMID: 20818855)
Eur J Cancer. 1998 Dec;34(14 Spec No):2253-63. (PMID: 10070296)
J Adolesc Young Adult Oncol. 2018 Jun;7(3):326-338. (PMID: 29373040)
Eur J Haematol Suppl. 2005 Jul;(66):135-40. (PMID: 16007882)
Cancer. 2007 Jul 1;110(1):179-85. (PMID: 17526010)
Klin Padiatr. 2015 Nov;227(6-7):314-21. (PMID: 26356319)
Br J Cancer. 2007 Dec 3;97(11):1588-94. (PMID: 17987032)
J Clin Oncol. 2007 Oct 10;25(29):4610-5. (PMID: 17925556)
Eur J Cancer. 2006 Sep;42(13):2037-49. (PMID: 16919769)
IARC Sci Publ. 1991;(95):126-58. (PMID: 1894318)
N Engl J Med. 1985 Jun 20;312(25):1604-8. (PMID: 4000199)
J Clin Oncol. 2016 Jan 20;34(3):235-43. (PMID: 26573075)
N Engl J Med. 2007 Nov 8;357(19):1916-27. (PMID: 17989384)
Eur J Cancer. 1997 Mar;33(3):436-41. (PMID: 9155529)
Br J Haematol. 2017 Jan;176(1):65-75. (PMID: 27766636)
Eur J Cancer. 2015 Nov;51(17):2643-54. (PMID: 26321503)
Cancer. 2018 Jan 1;124(1):136-144. (PMID: 28902390)
J Clin Oncol. 2017 Jul 10;35(20):2288-2298. (PMID: 28530852)
Eur J Cancer. 2001 Apr;37(6):703-10. (PMID: 11311644)
Pediatr Blood Cancer. 2004 Jul;43(1):8-16. (PMID: 15170884)
Br J Cancer. 2010 Nov 23;103(11):1663-70. (PMID: 21063404)
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103. (PMID: 24488779)
Ann Oncol. 1992 Sep;3 Suppl 4:73-6. (PMID: 1450084)
N Engl J Med. 1996 Mar 21;334(12):745-51. (PMID: 8592547)
J Clin Oncol. 2010 May 20;28(15):2625-34. (PMID: 20404250)
Cancer Epidemiol. 2016 Jun;42:72-81. (PMID: 27054577)
J Clin Oncol. 2003 Oct 1;21(19):3601-8. (PMID: 12913100)
Eur J Cancer. 1995 Oct;31A(11):1822-9. (PMID: 8541107)
N Engl J Med. 2003 Jun 12;348(24):2396-406. (PMID: 12802025)
Cancer. 2005 Apr 1;103(7):1457-67. (PMID: 15712273)
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1474-88. (PMID: 26215294)
J Am Heart Assoc. 2019 Jan 8;8(1):e009122. (PMID: 30595059)
Eur J Cancer. 2003 Dec;39(18):2611-21. (PMID: 14642923)
Acta Oncol. 2012 Sep;51(7):922-33. (PMID: 22934554)
Leukemia. 2016 Jan;30(1):24-31. (PMID: 26183645)
J Clin Oncol. 2012 May 1;30(13):1429-37. (PMID: 22473161)
Eur J Cancer. 2004 Jun;40(9):1351-60. (PMID: 15177495)
Radiother Oncol. 2006 Jun;79(3):270-7. (PMID: 16797755)
J Clin Oncol. 2015 Sep 20;33(27):2975-85. (PMID: 26304892)
Hematol Oncol. 2017 Jun;35 Suppl 1:60-66. (PMID: 28591411)
Eur J Cancer. 2017 Dec;87:38-46. (PMID: 29107860)
معلومات مُعتمدة: 207 International Stichting Kinderen Kankervrij; International Steunfonds Vrienden Integrale Oncologische Zorg
فهرسة مساهمة: Keywords: Hodgkin lymphoma; adolescent and young adult; cancer registry; paediatric oncology; population-based
تواريخ الأحداث: Date Created: 20200208 Date Completed: 20210125 Latest Revision: 20210125
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7318561
DOI: 10.1111/bjh.16491
PMID: 32030738
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-2141
DOI:10.1111/bjh.16491